The global hormone replacement therapy market size was US$ 35561.1 million in 2021. The global hormone replacement therapy market size is forecast to reach US$ 65377.8 million by 2030, growing at a compound annual growth rate (CAGR) of 7% during the forecast period from 2022 to 2030.
Replacement of natural hormones with hormones is called hormone replacement therapy (HRT). Human growth hormone and thyroid patients may receive hormone replacement therapy. Furthermore, HRT was commonly prescribed to menopausal women to relieve their symptoms such as hot flashes, night sweats, sleep disturbances, psychological and genito-urinary problems (urinary frequency and vaginal dryness), and to prevent osteoporosis. Furthermore, nearly 47% of the survey's 2,000 women aged 30 to 60 reported that at least one of the symptoms of a hormonal imbalance had affected them in 2019.
Factors Influencing Market Growth
Impact Analysis of COVID-19
Implementation of lockdown has negatively affected the hormone replacement therapy market. Moreover, the novel coronavirus exhibits a wide range of clinical presentations, severity, and mortality rates. In addition, fertility treatment and menopause have been adversely affected by the pandemic due to evidence that suggests declining estrogen levels could put older women at higher risk for the disease, and hormone withdrawal may accelerate the progression of COVID-19. Thus, the COVID-19 pandemic had a negative impact on the global market's growth.
Regional Insights
In terms of revenue, the North American market showed the most growth in 2021. As manufacturers launch a range of generic hormone replacement therapy products, the target population grows, technological advances in drug delivery systems and the development of new formulations are contributing to the growth of the regional market.
Asia-Pacific is forecast to have the highest CAGR in terms of revenue during the forecast period. Due to the growing awareness of hormone replacement therapy, the alarming increase in diabetes prevalence, and the increased focus of healthcare providers on reducing hormonal deficiencies in China, India, and Japan.
Leading Competitors
The leading prominent companies profiled in the global hormone replacement therapy market are:
Scope of the Report
The global hormone replacement therapy market segmentation focuses on Route of Administration, Therapy Type, Indication, and Region.
Segmentation based on Route of Administration
Segmentation based on Therapy Type
Segmentation based on Indication
Segmentation based on Region
Table of Content
1 INTRODUCTION OF GLOBAL HORMONE REPLACEMENT THERAPY MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL HORMONE REPLACEMENT THERAPY MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION
5.1 OVERVIEW
5.2 ORAL
5.3 PARENTAL
6 GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY THERAPYTYPE
6.1 OVERVIEW
6.2 ESTROGEN HORMONE REPLACEMENT THERAPY
6.3 HUMAN GROWTH HORMONE REPLACEMENT THERAPY
6.4 THYROID HORMONE REPLACEMENT THERAPY
6.5 TESTOSTERONE HORMONE REPLACEMENT THERAPY
6.6 PROGESTOGEN HORMONE REPLACEMENT THERAPY
7 GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION
6.1 OVERVIEW
6.2 MENOPAUSE
6.3 HYPOTHYROIDISM
6.4 MALE HYPOGONADISM
6.5 GROWTH HORMONE DEFICIENCY
6.6 OTHERS
8 MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1THE UK
8.3.2.2GERMANY
83.2.3FRANCE
8.3.2.4ITALY
8.3.2.5SPAIN
8.3.2.6REST OF WESTERN EUROPE
8.3.3EASTERN EUROPE
8.3.3.1POLAND
8.3.3.2RUSSIA
8.3.3.3REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL HORMONE REPLACEMENT THERAPY MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
10 COMPANY PROFILES
10.1 ABBOTT LABORATORIES
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.2 BAYER AG
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.3 ELI LILLY AND COMPANY
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.4 F. HOFFMANN-LA ROCHE LIMITED
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.5 HISAMITSU PHARMACEUTICAL CO., INCORPORATED
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.6 MERCK KGAA
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.7 MYLAN N.V.
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.8 NOVARTIS INTERNATIONAL AG
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.9 NOVO NORDISK A/S
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.10 PFIZER INCORPORATED
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved